CIK 0001714899 · Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463872213
- Phone
- (650) 866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-04 | Ho Carole Chief Medical Officer | Option exercise · Stock Option (right to buy) | −5,950 | 102,385 | ||
| 2019-01-04 | Watts Ryan J. President and CEO | Sale | −1,300 | $19.18 | $25K | 2,657,571 |
| 2019-01-04 | Watts Ryan J. President and CEO | Sale | −4,933 | $20.02 | $99K | 2,652,638 |
| 2019-01-03 | Ho Carole Chief Medical Officer | Option exercise | +5,775 | $5.28 | $30K | 183,900 |
| 2019-01-03 | Ho Carole Chief Medical Officer | Sale | −5,775 | $18.90 | $109K | 178,125 |
| 2019-01-03 | Ho Carole Chief Medical Officer | Option exercise · Stock Option (right to buy) | −5,775 | 72,825 | ||
| 2019-01-03 | Ho Carole Chief Medical Officer | Option exercise | +5,775 | $5.28 | $30K | 8,552 |
| 2019-01-03 | Ho Carole Chief Medical Officer | Sale | −2,777 | $18.90 | $52K | 2,777 |
| 2019-01-03 | Ho Carole Chief Medical Officer | Option exercise · Stock Option (right to buy) | −5,775 | 108,335 | ||
| 2019-01-03 | Watts Ryan J. President and CEO | Sale | −6,050 | $18.89 | $114K | 2,658,871 |
| 2019-01-02 | Ho Carole Chief Medical Officer | Option exercise | +5,775 | $5.28 | $30K | 183,900 |
| 2019-01-02 | Ho Carole Chief Medical Officer | Sale | −4,875 | $19.43 | $95K | 179,025 |
| 2019-01-02 | Ho Carole Chief Medical Officer | Sale | −900 | $20.24 | $18K | 178,125 |
| 2019-01-02 | Ho Carole Chief Medical Officer | Option exercise · Stock Option (right to buy) | −5,775 | 78,600 | ||
| 2019-01-02 | Ho Carole Chief Medical Officer | Sale | −4,875 | $19.43 | $95K | 143,515 |
| 2019-01-02 | Ho Carole Chief Medical Officer | Sale | −900 | $20.24 | $18K | 142,615 |
| 2019-01-02 | Watts Ryan J. President and CEO | Sale | −5,050 | $19.42 | $98K | 2,665,921 |
| 2019-01-02 | Watts Ryan J. President and CEO | Sale | −1,000 | $20.24 | $20K | 2,664,921 |
| 2018-12-12 | Schuth Alexander O. COO and Secretary | Sale | −2,500 | $20.80 | $52K | 677,589 |
| 2018-12-11 | Schuth Alexander O. COO and Secretary | Sale | −2,500 | $20.22 | $51K | 680,089 |
Page 45 of 53 · 1,053 trades